Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Roche has signed a voluntary license agreement providing its popular influenza antiviral drug Xofluza (baloxavir marboxil) for generic drugmakers to copy in 129 developing countries. | Roche has signed a voluntary license agreement providing its popular influenza antiviral drug Xofluza for generic drugmakers to copy in 129 developing countries.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

A new ranking of pharma companies by R&D performance

Full-Life Technologies raises $150M; Quince's reboot with pulmonary drug

Drugmakers guard IP more tightly amid China competition

Post-Hoc: The next big pharma company will come from China

Immunovant’s potential autoimmune ‘blockbuster’; Wave’s RNA editing update

Høeg fired in latest FDA shakeup; 20 people die after taking Amgen drug

The program will sell Xofluza through three pharmacies with a $50 cash pay option, which is 70% lower than the pill's current…

With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward…

Swiss pharmaceutical firm Roche is investing billions in new obesity treatments in hopes of breaking into a highly competitive…

With questions already swirling about the actual affordability impact of t | With questions already swirling about the actual…

A Novartis cross-border partnership is turning into a standoff. | A Novartis cross-border partnership is turning into a standoff.…

Maryland drug board to cap price of Ozempic, TrumpRx partners with Cuban, GoodRx, and more biotech news